Haematological malignancies: at the forefront of immunotherapeutic innovation

被引:67
作者
Bachireddy, Pavan [1 ,2 ,3 ,4 ]
Burkhardt, Ute E. [1 ,2 ]
Rajasagi, Mohini [1 ,2 ,3 ]
Wu, Catherine J. [1 ,2 ,3 ,4 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02215 USA
[3] Broad Inst, Cambridge, MA 02142 USA
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; REGULATORY T-CELLS; WT1 PEPTIDE VACCINATION; PHASE-II TRIAL; COLONY-STIMULATING FACTOR; MONOCLONAL-ANTIBODY THERAPY; AUTOLOGOUS DENDRITIC CELLS; MESENCHYMAL STROMAL CELLS; TUMOR-ASSOCIATED ANTIGENS;
D O I
10.1038/nrc3907
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The recent successes of cancer immunotherapies have stimulated interest in the potential widespread application of these approaches; haematological malignancies have provided both initial proofs of concept and an informative testing ground for various immune-based therapeutics. The immune-cell origin of many of the blood malignancies provides a unique opportunity both to understand the mechanisms of cancer immune responsiveness and immune evasion, and to exploit these mechanisms for therapeutic purposes.
引用
收藏
页码:201 / 215
页数:15
相关论文
共 214 条
[1]
Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma [J].
Advani, Ranjana ;
Forero-Torres, Andres ;
Furman, Richard R. ;
Rosenblatt, Joseph D. ;
Younes, Anas ;
Ren, Hong ;
Harrop, Kate ;
Whiting, Nancy ;
Drachman, Jonathan G. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) :4371-4377
[2]
Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma [J].
Ai, Weiyun Z. ;
Tibshirani, Robert ;
Taidi, Behnaz ;
Czerwinski, Debra ;
Levy, Ronald .
BLOOD, 2009, 113 (23) :5743-5746
[3]
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors [J].
Akbay, Esra A. ;
Koyama, Shohei ;
Carretero, Julian ;
Altabef, Abigail ;
Tchaicha, Jeremy H. ;
Christensen, Camilla L. ;
Mikse, Oliver R. ;
Cherniack, Andrew D. ;
Beauchamp, Ellen M. ;
Pugh, Trevor J. ;
Wilkerson, Matthew D. ;
Fecci, Peter E. ;
Butaney, Mohit ;
Reibel, Jacob B. ;
Soucheray, Margaret ;
Cohoon, Travis J. ;
Janne, Pasi A. ;
Meyerson, Matthew ;
Hayes, D. Neil ;
Shapiro, Geoffrey I. ;
Shimamura, Takeshi ;
Sholl, Lynette M. ;
Rodig, Scott J. ;
Freeman, Gordon J. ;
Hammerman, Peter S. ;
Dranoff, Glenn ;
Wong, Kwok-Kin .
CANCER DISCOVERY, 2013, 3 (12) :1355-1363
[4]
[Anonymous], BLOOD
[5]
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].
Ansell, Stephen M. ;
Lesokhin, Alexander M. ;
Borrello, Ivan ;
Halwani, Ahmad ;
Scott, Emma C. ;
Gutierrez, Martin ;
Schuster, Stephen J. ;
Millenson, Michael M. ;
Cattry, Deepika ;
Freeman, Gordon J. ;
Rodig, Scott J. ;
Chapuy, Bjoern ;
Ligon, Azra H. ;
Zhu, Lili ;
Grosso, Joseph F. ;
Kim, Su Young ;
Timmerman, John M. ;
Shipp, Margaret A. ;
Armand, Philippe .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319
[6]
Phase I Study of Ipilimumab, an Anti-CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma [J].
Ansell, Stephen M. ;
Hurvitz, Sara A. ;
Koenig, Patricia A. ;
LaPlant, Betsy R. ;
Kabat, Brian F. ;
Fernando, Donna ;
Habermann, Thomas M. ;
Inwards, David J. ;
Verma, Meena ;
Yamada, Reiko ;
Erlichman, Charles ;
Lowy, Israel ;
Timmerman, John M. .
CLINICAL CANCER RESEARCH, 2009, 15 (20) :6446-6453
[7]
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[8]
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial [J].
Armand, Philippe ;
Nagler, Arnon ;
Weller, Edie A. ;
Devine, Steven M. ;
Avigan, David E. ;
Chen, Yi-Bin ;
Kaminski, Mark S. ;
Holland, H. Kent ;
Winter, Jane N. ;
Mason, James R. ;
Fay, Joseph W. ;
Rizzieri, David A. ;
Hosing, Chitra M. ;
Ball, Edward D. ;
Uberti, Joseph P. ;
Lazarus, Hillard M. ;
Mapara, Markus Y. ;
Gregory, Stephanie A. ;
Timmerman, John M. ;
Andorsky, David ;
Or, Reuven ;
Waller, Edmund K. ;
Rotem-Yehudar, Rinat ;
Gordon, Leo I. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (33) :4199-4206
[9]
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein [J].
Bachanova, Veronika ;
Cooley, Sarah ;
Defor, Todd E. ;
Verneris, Michael R. ;
Zhang, Bin ;
McKenna, David H. ;
Curtsinger, Julie ;
Panoskaltsis-Mortari, Angela ;
Lewis, Dixie ;
Hippen, Keli ;
McGlave, Philip ;
Weisdorf, Daniel J. ;
Blazar, Bruce R. ;
Miller, Jeffrey S. .
BLOOD, 2014, 123 (25) :3855-3863
[10]
Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion [J].
Bachireddy, Pavan ;
Hainz, Ursula ;
Rooney, Michael ;
Pozdnyakova, Olga ;
Aldridge, Julie ;
Zhang, Wandi ;
Liao, Xiaoyun ;
Hodi, F. Stephen ;
O'Connell, Karyn ;
Haining, W. Nicholas ;
Goldstein, Natalie R. ;
Canning, Christine M. ;
Soiffer, Robert J. ;
Ritz, Jerome ;
Hacohen, Nir ;
Alyea, Edwin P., III ;
Kim, Haesook T. ;
Wu, Catherine J. .
BLOOD, 2014, 123 (09) :1412-1421